Skip to main content
Top
Published in: Neurocritical Care 2/2014

01-10-2014 | Review

THAM for Control of ICP

Authors: F. A. Zeiler, J. Teitelbaum, L. M. Gillman, M. West

Published in: Neurocritical Care | Issue 2/2014

Login to get access

Abstract

Our goal was to perform a systematic review of the literature on the use of tromethamine (THAM) and its effects on intracranial pressure (ICP) in patients with neurological illness. All articles from MEDLINE, BIOSIS, EMBASE, Global Health, HealthStar, Scopus, Cochrane Library, the International Clinical Trials Registry Platform (inception to February 2014), reference lists of relevant articles, and gray literature were searched. Two reviewers independently identified all manuscripts pertaining to the administration of THAM in human patients that recorded effects on ICP. Secondary outcomes of effect on cerebral perfusion pressure, mean arterial pressure, patient outcome, and adverse effects were recorded. Two reviewers independently extracted data including population characteristics and treatment characteristics. The strength of evidence was adjudicated using both the Oxford and GRADE methodology. Our search strategy produced a total 2,268 citations. Twelve articles, 9 manuscripts, and 3 meeting proceedings were considered for the review with all utilizing THAM while documenting ICP in neurosurgical patients. All studies were prospective. Across all studies, there were a total of 488 patients studied, with 263 receiving THAM and 225 serving as controls in a variety of heterogeneous studies. All but one study documented a decrease in ICP with THAM administration, with both bolus and continuous infusions. One study documented a reduction in cerebral perfusion pressure. No significant renal dysfunction, hepatocellular injury, or hypoglycemia were reported. Three prospective randomized control trials displayed trends to improved outcome in severe traumatic brain injury (TBI) patients with THAM administration. There currently exists Oxford level 2b, GRADE B evidence to support that THAM reduces ICP in the TBI and malignant ischemic infarct population, with minimal side effects. The literature suggests THAM may be useful for ICP reduction in certain cases, though the safety of the compound in these circumstances is still unclear. Further prospective study is warranted.
Appendix
Available only for authorised users
Literature
1.
go back to reference DeSalles AAF, Kontos HA, Becker DP, Yang MS, Ward JD, Moulton R, et al. Prognostic significance of ventricular CSF lactic acidosis in severe head injury. J Neurosurg. 1986;65:615–24.PubMedCrossRef DeSalles AAF, Kontos HA, Becker DP, Yang MS, Ward JD, Moulton R, et al. Prognostic significance of ventricular CSF lactic acidosis in severe head injury. J Neurosurg. 1986;65:615–24.PubMedCrossRef
2.
go back to reference Yao H, Haddad GG. Calcium and pH homeostasis in neurons during hypoxia and ischemia. Cell Calcium. 2004;36:247–55.PubMedCrossRef Yao H, Haddad GG. Calcium and pH homeostasis in neurons during hypoxia and ischemia. Cell Calcium. 2004;36:247–55.PubMedCrossRef
3.
go back to reference Staub F, Baethmann A, Peters J, Weigt H, Kempski O. Effects of lactacidosis on glial cell volume and viability. J Cereb Blood Flow Metab. 1990;10:866–76.PubMedCrossRef Staub F, Baethmann A, Peters J, Weigt H, Kempski O. Effects of lactacidosis on glial cell volume and viability. J Cereb Blood Flow Metab. 1990;10:866–76.PubMedCrossRef
4.
go back to reference Staub F, Winkler A, Peters J, Kempski O, Kachel V, Baethmann A. Swelling, acidosis, and irreversible damage of glial cells from exposure to arachidonic acid in vitro. J Cereb Blood Flow Metab. 1994;14:1030–9.PubMedCrossRef Staub F, Winkler A, Peters J, Kempski O, Kachel V, Baethmann A. Swelling, acidosis, and irreversible damage of glial cells from exposure to arachidonic acid in vitro. J Cereb Blood Flow Metab. 1994;14:1030–9.PubMedCrossRef
5.
go back to reference Tran ND, Kim S, Vincent HK, Rodriguez A, Hinton DR, Bullock MR, et al. Aquaporin-1-mediated cerebral edema following traumatic brain injury: effects of acidosis and corticosteroid administration. J Neurosurg. 2010;112:1095–104.PubMedCrossRef Tran ND, Kim S, Vincent HK, Rodriguez A, Hinton DR, Bullock MR, et al. Aquaporin-1-mediated cerebral edema following traumatic brain injury: effects of acidosis and corticosteroid administration. J Neurosurg. 2010;112:1095–104.PubMedCrossRef
6.
go back to reference Nahas GG, Sutin KM, Fermon C, Streat S, Wikland L, Wahlander S, et al. Guidelines for the treatment of acidemia with THAM. Drugs. 1998;55(2):191–224.PubMedCrossRef Nahas GG, Sutin KM, Fermon C, Streat S, Wikland L, Wahlander S, et al. Guidelines for the treatment of acidemia with THAM. Drugs. 1998;55(2):191–224.PubMedCrossRef
8.
go back to reference Jantzen JPAH. Prevention and treatment of intracranial hypertension. Best Pract Res Clin Anaesthesiol. 2007;21(4):517–38.PubMedCrossRef Jantzen JPAH. Prevention and treatment of intracranial hypertension. Best Pract Res Clin Anaesthesiol. 2007;21(4):517–38.PubMedCrossRef
9.
go back to reference Juttler E, Schellinger PD, Aschoff A, Zweckberger K, Unterberg A, Hacke W. Clinical review: therapy for refractory intracranial hypertension in ischemic stroke. Crit Care. 2007;11(5):231.PubMedCrossRefPubMedCentral Juttler E, Schellinger PD, Aschoff A, Zweckberger K, Unterberg A, Hacke W. Clinical review: therapy for refractory intracranial hypertension in ischemic stroke. Crit Care. 2007;11(5):231.PubMedCrossRefPubMedCentral
10.
go back to reference Maas AIR, Roozenbeek B, Manley GT. Clinical trials in traumatic brain injury: past experience and current developments. Neurotherapeutics. 2009;7(1):115–26.CrossRef Maas AIR, Roozenbeek B, Manley GT. Clinical trials in traumatic brain injury: past experience and current developments. Neurotherapeutics. 2009;7(1):115–26.CrossRef
12.
go back to reference Marmarou A, Holdaway R, Ward JD, Yoshida K, Choi SC, Muizelaar JP, et al. Traumatic brain tissue acidosis: experimental and clinical studies. Acta Neurochir. 1993;57(Suppl):160–7. Marmarou A, Holdaway R, Ward JD, Yoshida K, Choi SC, Muizelaar JP, et al. Traumatic brain tissue acidosis: experimental and clinical studies. Acta Neurochir. 1993;57(Suppl):160–7.
13.
go back to reference Dos SD, Lande AJ, Lillihei CW. Hypercapneic cerebrospinal fluid hypertension: a pharmacological study. Surgery. 1968;63(5):788–99.PubMed Dos SD, Lande AJ, Lillihei CW. Hypercapneic cerebrospinal fluid hypertension: a pharmacological study. Surgery. 1968;63(5):788–99.PubMed
14.
go back to reference Duthie SE, Goulin GD, Zornow MH, Scheller MS, Peterson BM. Effects of THAM and sodium bicarbonate on intracranial pressure and mean arterial pressure in an animal model of focal cerebral injury. J Neurosurg Anesthesiol. 1994;6(3):201–8.PubMedCrossRef Duthie SE, Goulin GD, Zornow MH, Scheller MS, Peterson BM. Effects of THAM and sodium bicarbonate on intracranial pressure and mean arterial pressure in an animal model of focal cerebral injury. J Neurosurg Anesthesiol. 1994;6(3):201–8.PubMedCrossRef
15.
go back to reference Rosner MJ, Becker DP. Experimental brain injury: successful therapy with the weak base, tromethamine. J Neurosurg. 1984;60:961–71.PubMedCrossRef Rosner MJ, Becker DP. Experimental brain injury: successful therapy with the weak base, tromethamine. J Neurosurg. 1984;60:961–71.PubMedCrossRef
16.
go back to reference Chang W, Li Q, Cao H. Therapeutic effect of THAM in lactic acidosis of severe brain injury. Chung-Hua Wai Ko Tsa Chih [Chinese Journal of Surgery]. 1996;34(6):364–7. Chang W, Li Q, Cao H. Therapeutic effect of THAM in lactic acidosis of severe brain injury. Chung-Hua Wai Ko Tsa Chih [Chinese Journal of Surgery]. 1996;34(6):364–7.
17.
go back to reference Fox JL. Reduction of intracranial pressure by THAM during brain surgery. Med Ann Dist Columbia. 1964;33:269–73.PubMed Fox JL. Reduction of intracranial pressure by THAM during brain surgery. Med Ann Dist Columbia. 1964;33:269–73.PubMed
18.
go back to reference Gaab MR, Seegers K, Smedema RJ, Heissler HE, Goetz C. Acta Neurochir Suppl. 1990;51:320–3.PubMed Gaab MR, Seegers K, Smedema RJ, Heissler HE, Goetz C. Acta Neurochir Suppl. 1990;51:320–3.PubMed
19.
go back to reference Keller E, Steiner T, Fandino J, Schwab S, Hacke W. Jugular venous oxygen saturation thresholds in trauma patients may not extrapolate to ischemic stroke patients. J Neurosurg Anesthesiol. 2002;14(2):130–6.PubMedCrossRef Keller E, Steiner T, Fandino J, Schwab S, Hacke W. Jugular venous oxygen saturation thresholds in trauma patients may not extrapolate to ischemic stroke patients. J Neurosurg Anesthesiol. 2002;14(2):130–6.PubMedCrossRef
20.
go back to reference Muizelaar JP, Marmarou A, Ward JD, Kontos HA, Choi SC, Becker DP, et al. Adverse effects of prolonged hyperventilation in patients with severe head injury: a randomized clinical trial. J Neurosurg. 1991;75:731–9.PubMedCrossRef Muizelaar JP, Marmarou A, Ward JD, Kontos HA, Choi SC, Becker DP, et al. Adverse effects of prolonged hyperventilation in patients with severe head injury: a randomized clinical trial. J Neurosurg. 1991;75:731–9.PubMedCrossRef
21.
go back to reference Pfenninger E, Linder KH, Ahnefeld FW. Use of THAM (tris-hydroxymethylaminomethan) for rapid control of high intracranial pressure in severe head injury. Anaesthesist. 1989;38:189–92.PubMed Pfenninger E, Linder KH, Ahnefeld FW. Use of THAM (tris-hydroxymethylaminomethan) for rapid control of high intracranial pressure in severe head injury. Anaesthesist. 1989;38:189–92.PubMed
22.
go back to reference Rosner MJ, Elias KG, Coley I. Prospective, randomized trial of THAM therapy in severe brain injury: preliminary results. In: Hoff JT, BetzI AL, editors. Intracranial pressure VII. Berlin: Springer-Verlag; 1989. p. 611–5.CrossRef Rosner MJ, Elias KG, Coley I. Prospective, randomized trial of THAM therapy in severe brain injury: preliminary results. In: Hoff JT, BetzI AL, editors. Intracranial pressure VII. Berlin: Springer-Verlag; 1989. p. 611–5.CrossRef
23.
go back to reference Schwab S, Schellinger P, Aschoff A, Albert F, Spranger M, Hacke W. Epidurale hirndruckmessung und hirndrucktherapie bei “malignem” mediainfarkt. Nervenarzt. 1996;67:659–66.PubMedCrossRef Schwab S, Schellinger P, Aschoff A, Albert F, Spranger M, Hacke W. Epidurale hirndruckmessung und hirndrucktherapie bei “malignem” mediainfarkt. Nervenarzt. 1996;67:659–66.PubMedCrossRef
24.
go back to reference Steiner T, Pilz J, Schellinger P, Wirtz R, Friederichs V, Aschoff A, et al. Multimodal online monitoring in middle cerebral artery territory stroke. Stroke. 2001;32:2500–6.PubMedCrossRef Steiner T, Pilz J, Schellinger P, Wirtz R, Friederichs V, Aschoff A, et al. Multimodal online monitoring in middle cerebral artery territory stroke. Stroke. 2001;32:2500–6.PubMedCrossRef
25.
go back to reference Ward JD, Choi S, Marmarou A, Moulton R, Muizelaar JP, DeSalles A, et al. Effect of prophylactic hyperventilation on outcome in patients with severe head injury. In: Hoff JT, BetzI AL, editors. Intracranial pressure VII. Berlin: Springer-Verlag; 1989. p. 630–3.CrossRef Ward JD, Choi S, Marmarou A, Moulton R, Muizelaar JP, DeSalles A, et al. Effect of prophylactic hyperventilation on outcome in patients with severe head injury. In: Hoff JT, BetzI AL, editors. Intracranial pressure VII. Berlin: Springer-Verlag; 1989. p. 630–3.CrossRef
26.
go back to reference Wolf AL, Levi L, Marmarou A, Ward JD, Muizelaar PJ, Choi S, et al. Effect of THAM on outcome in severe head injury: a randomized prospective trial. J Neurosurg. 1993;78:54–9.PubMedCrossRef Wolf AL, Levi L, Marmarou A, Ward JD, Muizelaar PJ, Choi S, et al. Effect of THAM on outcome in severe head injury: a randomized prospective trial. J Neurosurg. 1993;78:54–9.PubMedCrossRef
27.
go back to reference Wolf AL, Levi L, Marmarou A, Ward JD, Rigamonti D, Muizelaar JP, et al. A prospective randomized clinical trial of tromethamine (THAM) and its effects on outcome in severe head injury. In: Avezaat CJJ, et al., editors. Intracranial pressure VIII. Berlin: Springer-Verlag; 1993. p. 615–9.CrossRef Wolf AL, Levi L, Marmarou A, Ward JD, Rigamonti D, Muizelaar JP, et al. A prospective randomized clinical trial of tromethamine (THAM) and its effects on outcome in severe head injury. In: Avezaat CJJ, et al., editors. Intracranial pressure VIII. Berlin: Springer-Verlag; 1993. p. 615–9.CrossRef
29.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analysis: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.PubMedCrossRef Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analysis: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.PubMedCrossRef
31.
go back to reference Guyatt GH, Oxman AD, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. Rating quality of evidence and strength of recommendations GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–6.PubMedCrossRefPubMedCentral Guyatt GH, Oxman AD, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. Rating quality of evidence and strength of recommendations GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–6.PubMedCrossRefPubMedCentral
32.
go back to reference Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ, et al. Rating quality of evidence and strength of recommendations: what is “quality of evidence” and why is it important to clinicians? BMJ. 2008;336(7651):995–8.PubMedCrossRefPubMedCentral Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ, et al. Rating quality of evidence and strength of recommendations: what is “quality of evidence” and why is it important to clinicians? BMJ. 2008;336(7651):995–8.PubMedCrossRefPubMedCentral
33.
go back to reference Schünemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. 2008;336(7653):1106–10.PubMedCrossRefPubMedCentral Schünemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. 2008;336(7653):1106–10.PubMedCrossRefPubMedCentral
34.
go back to reference Guyatt GH, Oxman AD, Kunz R, Jaeschke R, Helfand M, Liberati A, et al. Rating quality of evidence and strength of recommendations: incorporating considerations of resources use into grading recommendations. BMJ. 2008;336(7654):1170–3.PubMedCrossRefPubMedCentral Guyatt GH, Oxman AD, Kunz R, Jaeschke R, Helfand M, Liberati A, et al. Rating quality of evidence and strength of recommendations: incorporating considerations of resources use into grading recommendations. BMJ. 2008;336(7654):1170–3.PubMedCrossRefPubMedCentral
35.
go back to reference Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, et al. Rating quality of evidence and strength of recommendations: going from evidence to recommendations. BMJ. 2008;336(7652):1049–51.PubMedCrossRefPubMedCentral Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, et al. Rating quality of evidence and strength of recommendations: going from evidence to recommendations. BMJ. 2008;336(7652):1049–51.PubMedCrossRefPubMedCentral
36.
go back to reference Jaeschke R, Guyatt GH, Dellinger P, Schünemann H, Levy MM, Kunz R, et al. Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ. 2008;337:a744.PubMedCrossRef Jaeschke R, Guyatt GH, Dellinger P, Schünemann H, Levy MM, Kunz R, et al. Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ. 2008;337:a744.PubMedCrossRef
Metadata
Title
THAM for Control of ICP
Authors
F. A. Zeiler
J. Teitelbaum
L. M. Gillman
M. West
Publication date
01-10-2014
Publisher
Springer US
Published in
Neurocritical Care / Issue 2/2014
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-014-9978-7

Other articles of this Issue 2/2014

Neurocritical Care 2/2014 Go to the issue